Please assess the completion status of the following clinical trial:

Trial Title: Plasmalyte Versus Saline in Trauma Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Severe trauma defined by at least one Vittel criteria~* Prescription for at least one red blood cell unit transfusion within 6 hours after trauma~* Delay between trauma and study randomization ≤ 6 hours~* Patient able to give consent or included in emergency situation~* Patient affiliated to Health security system~Exclusion Criteria:~* Age \< 18 years~* Chronic kidney disease needing requiring renal replacement therapy~* Participation to another interventional trial interacting with renal function or which requires the use of a fluid resuscitation~* Fluid resuscitation \> 4000 mL before inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Plasmalyte Viaflo (Type: EXPERIMENTAL): Intervention type: drug (Plasmalyte Viaflo) Intervention name: plasmalyte Intervention description: fluid resuscitation using exclusively Plasmalyte up to 20L during the first 5 days
- NaCl 0.9% (Type: ACTIVE_COMPARATOR): Intervention type: drug (NaCl 0.9%) Intervention name: NaCl 0.9% Intervention description: fluid resuscitation using exclusively NaCl 0.9% up to 20L during the first 5 days

Based on this trial design, predict the completion outcome and termination type (if applicable).